Effectiveness of Clozapine Versus Olanzapine for Treatment-Resistant Schizophrenia

This study has been terminated.

Sponsor:

Collaborators:

Dartmouth-Hitchcock Medical Center

Harvard Medical School

Commonwealth Research Center, Massachusetts

Eli Lilly and Company

Information provided by:

National Institute of Mental Health (NIMH)

ClinicalTrials.gov Identifier:

NCT00169065

First received: September 10, 2005

Last updated: February 21, 2006

Last verified: September 2005

No Study Results Posted on ClinicalTrials.gov for this Study

Study Status:	This study has been terminated.
Estimated Study Completion Date:	No date given
Estimated Primary Completion Date:	No date given